D05.01
Lobular carcinoma in situ of right breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Lobular carcinoma in situ (LCIS) of the right breast is a condition characterized by abnormal cell growth confined to the lobules, the milk-producing glands within the breast. While LCIS itself is not considered cancer, it indicates an increased risk of developing invasive breast cancer in the future. Recognizing and understanding this condition can help in making informed decisions about breast health and management options.
Causes & Symptoms
Clinical Causes: Genetic factors that increase breast tissue vulnerability Hormonal influences, especially prolonged exposure to estrogen Family history of breast cancer or other genetic predispositions Environmental factors and lifestyle choices such as alcohol consumption or obesity
Key Symptoms: Usually no physical signs or symptoms; often found incidentally during screening Possible detection through routine mammography or breast imaging In rare cases, a lump or thickening may be felt in the breast
Diagnostic & Treatment
Diagnosis Path: Diagnosis of LCIS often involves a combination of imaging studies and tissue sampling. Typically, mammography is used for screening, which may reveal subtle changes in breast tissue. If suspicious areas are found, a biopsy — such as a core needle biopsy — is performed to examine tissue cells microscopically. Pathological analysis confirms the presence of LCIS and rules out invasive cancer. Additional imaging, like breast MRI, might be recommended for a comprehensive assessment.
Treatment Protocols: Active surveillance with regular mammograms and clinical exams to monitor any changes in breast tissue Hormonal therapy, such as tamoxifen or raloxifene, may be considered to reduce the risk of developing invasive breast cancer Lifestyle modifications, including maintaining a healthy weight, limiting alcohol, and exercising regularly In some cases, surgical options like removal of the affected tissue might be discussed, especially if there are additional risk factors
Clinical Advice & FAQs
Billing Guidance
Is D05.01 a billable ICD-10 code?
Yes, D05.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D05.01?
Clinical documentation must specify the nature of Lobular carcinoma in situ of right breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
